Ali Khademhosseini

Ali Khademhosseini (Persian: علی خادم‌حسینی‎, born October 30, 1975, Tehran, Iran) is the Director and CEO of the Terasaki Institute and former Professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering and the Director of Center for Minimally Invasive Therapeutics (C-MIT).[1] From 2005 to 2017, he was a Professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering. His studies have been cited over 70,000 times.[2] Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting.

Ali Khademhosseini
Khademhosseini in 2008
Born (1975-10-30) October 30, 1975
Tehran, Iran
CitizenshipIran, Canada, United States
Alma mater
Scientific career
Fields
Institutions
Theses
Doctoral advisorRobert S. Langer
Other academic advisorsPeter Zandstra
Notable studentsAkhilesh K. Gaharwar

Khademhosseini is a recipient of The Massachusetts Institute of Technology Outstanding Undergraduate mentor award and a recipient of the Presidential Career Award for Scientists and Engineers by President Barack Obama.[3]

From 2014 to 2020 he has been selected by Thomson Reuters as one of the World's Most Influential Minds.[4]

Background and Personal Life

Khademhosseini was born in Tehran, Iran, and grew up in Toronto, Canada. He received his Ph.D. in bioengineering from MIT under the supervision of Robert S. Langer (2005), and MASc (2001) and BASc (1999) degrees from the University of Toronto both in chemical engineering.

Awards and Honors

Dr. Khademhosseini’s interdisciplinary research has been recognized over 70 major national and international awards. He is a recipient of the 2011 Presidential Early Career Award for Scientists and Engineers (PECASE) by President Barack Obama, the highest honor given by the US government for early-career investigators.[5] In 2007, he was named a TR35 recipient by the Technology Review Magazine as one of the world’s top young innovators. In 2011, he received the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (RSC) for his contribution to microscale tissue engineering and microfluidics. In 2016, he received the Sr. Scientist Award of Tissue Engineering and Regenerative Medicine Society-Americas (TERMIS-AM) and in 2017 he received the Clemson Award of the Society for Biomaterials. In addition, he has received the young investigator awards of the Society for Biomaterials and the Tissue Engineering and Regenerative Medicine International Society-North America. He has also received the American Chemical Society's Viktor K. Lamer award and the Unilever award and has been recognized by major governmental Awards including the NSF Career award and the Office of Naval Research Young Investigator award. He has been elected into the Canadian Academy of Engineering as well as the Royal Society of Canada. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). In 2019, he received the Mustafa Prize, for his work on microfabricated hydrogel for biomedical applications.[6]

References
  1. "Ali Khademhosseini Ph.D. | BE". www.bioeng.ucla.edu. Retrieved 2018-01-07.
  2. "Ali Khademhosseini - Google Scholar Citations". scholar.google.com. Retrieved 2017-09-12.
  3. "President Obama Honors Outstanding Early-Career Scientists". Office of the Press Secretary. 2011-09-26. Retrieved 26 September 2011.
  4. "The World's Most Influential Scientific Minds 2015-Thomson Reuters (2016).pdf | Citation | Science". Scribd. Retrieved 2018-03-03.
  5. "President Obama Honors Outstanding Early-Career Scientists". Office of the Press Secretary. 2011-09-26. Retrieved 26 September 2011.
  6. "Mustafa Prize 2019". Retrieved 2020-10-21.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.